-
- Eugene Varfolomeev
- Department of Early Discovery Biochemistry, Genentech, South San Francisco, CA 94110, U.S.A.
-
- Domagoj Vucic
- Department of Early Discovery Biochemistry, Genentech, South San Francisco, CA 94110, U.S.A.
抄録
<jats:p>Receptor interacting protein 1 (RIP1) kinase is a critical regulator of inflammation and cell death signaling, and plays a crucial role in maintaining immune responses and proper tissue homeostasis. Mounting evidence argues for the importance of RIP1 post-translational modifications in control of its function. Ubiquitination by E3 ligases, such as inhibitors of apoptosis (IAP) proteins and LUBAC, as well as the reversal of these modifications by deubiquitinating enzymes, such as A20 and CYLD, can greatly influence RIP1 mediated signaling. In addition, cleavage by caspase-8, RIP1 autophosphorylation, and phosphorylation by a number of signaling kinases can greatly impact cellular fate. Disruption of the tightly regulated RIP1 modifications can lead to signaling disbalance in TNF and/or TLR controlled and other inflammatory pathways, and result in severe human pathologies. This review will focus on RIP1 and its many modifications with an emphasis on ubiquitination, phosphorylation, and cleavage, and their functional impact on the RIP1's role in signaling pathways.</jats:p>
収録刊行物
-
- Biochemical Journal
-
Biochemical Journal 479 (9), 929-951, 2022-05-06
Portland Press Ltd.